Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

165.66
-0.9200-0.55%
Post-market: 165.55-0.1099-0.07%18:21 EDT
Volume:7.93M
Turnover:1.32B
Market Cap:43.02B
PE:-11.65
High:167.08
Open:166.50
Low:165.58
Close:166.58
52wk High:176.60
52wk Low:133.73
Shares:259.67M
Float Shares:259.67M
Volume Ratio:1.02
T/O Rate:3.06%
Dividend:2.53
Dividend Rate:1.53%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.25
PE(LYR):-11.65

Loading ...

Health Care Down as Novartis, Boston Scientific Weigh - Health Care Roundup

Dow Jones
·
Sep 09

Tenet Healthcare Prices Upsized $2 Billion Notes Offering

MT Newswires Live
·
Sep 09

Molina Healthcare Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented

Reuters
·
Sep 09

Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference

GlobeNewswire
·
Sep 09

Health Care Roundup: Market Talk

Dow Jones
·
Sep 09

Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

UnitedHealth to Present Strategy at Wells Fargo Conference

TIPRANKS
·
Sep 09

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Protagonist Therapeutics Launches USD 300 Million Share Buyback Program

Reuters
·
Sep 09

Cycurion Secures New Healthcare and Public Health Contracts

TIPRANKS
·
Sep 09

Analyst Maintains Buy on Sarepta, Keeping $35 Price Target Amid Confidence in DM1 Franchise and α‑Integrin Delivery Platform

TIPRANKS
·
Sep 09

Headlands Research Names Brandon Pallott Chief Commercial Officer

Reuters
·
Sep 09

Grindr Sees Large Healthcare Revenue Opportunity, Morgan Stanley Says

Dow Jones
·
Sep 09

ICU Girişim Sermayesi Details Diversified Venture Portfolio in Healthcare and Technology

TIPRANKS
·
Sep 09

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

TIPRANKS
·
Sep 09

Dennis Ding Reiterates Buy on Tarsus, Highlighting Robust Xdemvy Trends, Conservative 2026 Guidance, and Attractive Valuation Backed by Late-Stage Pipeline

TIPRANKS
·
Sep 09

Analysts’ Top Healthcare Picks: Spyre Therapeutics (SYRE), BioCryst (BCRX)

TIPRANKS
·
Sep 09

Analysts Are Bullish on These Healthcare Stocks: enGene Holdings (ENGN), Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TIPRANKS
·
Sep 09

Sell Rating Reaffirmed on Weakening Core Franchise and Elevated Clinical Risk; $5 Price Target Unchanged

TIPRANKS
·
Sep 09